CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,012,000 | -22.4% | 76,000 | 0.0% | 1.56% | -14.1% |
| Q4 2017 | $5,168,000 | +12.0% | 76,000 | +35.7% | 1.82% | +1.4% |
| Q3 2017 | $4,614,000 | +40.8% | 56,000 | +60.0% | 1.80% | +44.3% |
| Q2 2017 | $3,276,000 | +157.3% | 35,000 | +75.0% | 1.24% | +155.6% |
| Q1 2017 | $1,273,000 | -61.8% | 20,000 | -73.3% | 0.49% | -67.6% |
| Q4 2016 | $3,332,000 | – | 75,000 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |